Curis develops Erivedge, a capsule manufactured for the treatment of adults with skin cancer. read more
Curis CEO & Leadership Team Ratings
Ali Fattaey and the Curis leadership team are scored a "C-" by 4 employees placing it in the Bottom 30% of companies sized 11-50 Employees on Comparably. The Leadership Score of 64/100 is based on 17 ratings; it combines employee feedback on their CEO (65/100), Manager (52/100), and Executive Team (60/100).
Ali Fattaey Curis CEO Rating
Bottom 25% Compared to other companies of similar size in BostonD+
65 / 100
Ali Fattaey the CEO of Curis received an average score of 65 from Curis employees.Curis Manager Rating
Bottom 10% Compared to other companies of similar size in BostonD-
52 / 100
Curis Executive Team Rating
Bottom 20% Compared to other companies of similar size in BostonD
60 / 100
×